JOHN FOREYT to Cardiovascular Diseases
This is a "connection" page, showing publications JOHN FOREYT has written about Cardiovascular Diseases.
Connection Strength
1.518
-
Association Between Change in Accelerometer-Measured and Self-Reported Physical Activity and Cardiovascular Disease in the Look AHEAD Trial. Diabetes Care. 2022 03 01; 45(3):742-749.
Score: 0.329
-
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Curr Atheroscler Rep. 2014 Dec; 16(12):457.
Score: 0.199
-
Implications of Look AHEAD for clinical trials and clinical practice. Diabetes Obes Metab. 2014 Dec; 16(12):1183-91.
Score: 0.097
-
Migration history, health behaviors, and cardiovascular disease risk factors in overweight Mexican-American women. Ethn Dis. 2003; 13(1):94-108.
Score: 0.087
-
For the patient. The importance of health behaviors for better heart health. Migration history, health behaviors, and cardiovascular disease risk factors in overweight Mexican-American women. Ethn Dis. 2003; 13(1):152.
Score: 0.087
-
Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010 Sep 27; 170(17):1566-75.
Score: 0.075
-
History of Cardiovascular Disease, Intensive Lifestyle Intervention, and Cardiovascular Outcomes in the Look AHEAD Trial. Obesity (Silver Spring). 2020 02; 28(2):247-258.
Score: 0.071
-
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008 Mar 05; 299(9):1036-45.
Score: 0.062
-
Unique effect for fructose on lipoprotein risk factors for cardiovascular disease in children is not demonstrated. Atherosclerosis. 2016 12; 255:219-220.
Score: 0.057
-
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016 11; 4(11):913-921.
Score: 0.056
-
Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care. 2014 Sep; 37(9):2548-56.
Score: 0.049
-
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11; 369(2):145-54.
Score: 0.045
-
A one-year school-based diet/exercise intervention improves non-traditional disease biomarkers in Mexican-American children. Matern Child Nutr. 2013 Oct; 9(4):524-32.
Score: 0.041
-
Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study. Clin Trials. 2012 Feb; 9(1):113-24.
Score: 0.041
-
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007 Jun; 30(6):1374-83.
Score: 0.029
-
Evaluation of a primary care-oriented brief counselling intervention for obesity with and without orlistat. J Intern Med. 2006 Oct; 260(4):388-98.
Score: 0.028
-
Diet and health. West J Med. 1984 Dec; 141(6):872-7.
Score: 0.025
-
Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification. Int J Obes Relat Metab Disord. 2003 Dec; 27(12):1486-93.
Score: 0.023
-
Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial. Obesity (Silver Spring). 2012 Aug; 20(8):1675-82.
Score: 0.020
-
Factors influencing enrollment of African Americans in the Look AHEAD trial. Clin Trials. 2012 Feb; 9(1):80-9.
Score: 0.020
-
Describing patterns of weight changes using principal components analysis: results from the Action for Health in Diabetes (Look AHEAD) research group. Ann Epidemiol. 2009 Oct; 19(10):701-10.
Score: 0.017
-
Plasma lipid changes in the normal population following behavioral treatment. J Consult Clin Psychol. 1979 Jun; 47(3):440-52.
Score: 0.017
-
Obesity. Workshop III. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health. Circulation. 1993 Sep; 88(3):1391-6.
Score: 0.011
-
Obese Mexican American children have elevated MCP-1, TNF-a, monocyte concentration, and dyslipidemia. Pediatrics. 2012 May; 129(5):e1180-6.
Score: 0.010
-
Constructing common cohorts from trials with overlapping eligibility criteria: implications for comparing effect sizes between trials. Clin Trials. 2009 Oct; 6(5):416-29.
Score: 0.009
-
Treatment of the metabolic syndrome: the impact of lifestyle modification. Curr Atheroscler Rep. 2005 Mar; 7(2):95-102.
Score: 0.006
-
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999 Jan 20; 281(3):235-42.
Score: 0.004